BME.L - Risk

Elevated Business & Solvency Risk

Caution: In addition to price volatility, there are balance sheet risks due to higher debt or weaker liquidity (Health Score: 50/100).

Volatility Risk

Transparent evaluation of price volatility (SRI), Beta, and historical drawdowns.

Volatility Risk Score

7/7 Very High

7 / 7 SRI Price Fluctuation & Beta

Very high volatility or fundamental risks. Significant loss potential; strictly for aggressive investors. Largely moves in line with the broader market.

Beta (Market Relation)

1.1x

Above average

Volatility (5Y p.a.)

35.5% p.a.

5-Year Horizon

Max Drawdown (5Y)

-75.9%

5-Year Horizon

Sharpe Ratio

-0.48

Return / Risk

Speculative / High Risk: Score Basis:

Multi-Horizon Risk & Performance Matrix

Historical volatility, drawdowns, and risk-adjusted return across 1, 3, 5, and 10 years.

Volatility Expansion (3Y > 5Y) High Volatility

Timeframe	Volatility (p.a.)	Max Drawdown	Sharpe Ratio	Return (p.a.)
1 Year	—	—	—	+9.4%
3 Years	37.6%	-74.7%	-0.68	-23.2%
5 Years	35.5%	-75.9%	-0.48	-14.6%
10 Years	31.3%	-75.9%	-0.06	+0.6%

Automated Risk & Health Notes (Red Flags)

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).

Critical leverage: Debt-to-Equity is at 307%.

Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (35.5% p.a.).

Historical Stress Test: Maximum peak-to-trough drawdown of -75.9% in the extended horizon.

Corporate Governance & ISS Scores

Shareholder rights, board structure and audit safety (Scale 1 = Low Risk, 10 = High Risk)

Overall Governance Risk

2 ISS Score: 2 / 10

Audit Risk

3 ISS Score: 3 / 10

Board Risk

2 ISS Score: 2 / 10

Short Ratio